The Asian Liver Center at Stanford University is the first non-profit organization in the United States that addresses the disproportionately high rates of chronic hepatitis B infection and liver cancer in Asians and Asian Americans. Founded in 1996 by Dr. Sam So, the Center aims to eliminate the transmission and stigma of hepatitis B, and reduce deaths from liver cancer and liver disease caused by chronic hepatitis B.
Website: Stanford Medicine Asian Liver Center
The Fellowship program is to honor Professor Stephen Locarnini (Doherty Institute, Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia) whose legendary research and public health contributions in viral infectious diseases and hepatitis has advanced the fields in terms of molecular virology, diagnosis, treatment and control of viral diseases. The Locarnini Fellowship provides support to a talented post-doctoral fellow or young investigator who is specializing in the field of virology. Dr Sushama Telwatte is awarded the inaugural Locarnini Fellowship in Virology at the Doherty Institute.
Website: Dr Sushama Telwatte Awarded Locarnini Fellowship in Virology
Since its inception in 1995, HEP DART has established itself as an internationally recognized biennial conference that provides an important platform for scientists and clinicians to share and discuss the latest advancements in the field of viral hepatitis and liver disease.
Website: HepDART 2021
In honor of the long-term collaborations between Professors Salim and Quarraisha Abdool Karim (CAPRISA) with John Martin on HIV research and prevention of transmission, a John C. Martin Chair of Global Health and a John C. Martin Training Program for Infectious Diseases in Developing Countries were endowed at the University of KwaZulu Natal, Durban, South Africa. Professors Abdool Karim led the groundbreaking study CAPRISA-004 over 20 years ago using Tenofovir-DF gel which forged the global landscape of HIV PrEP.
Professor Quarraisha, the first holder of the Chair, was the leading principal investigator for recent PURPOSE-1 study, which unprecedently, demonstrated prevention of HIV can be absolute by twice yearly injection of Lenacapavir. Their leadership in saving lives through clinical investigations and global health advocacy were recognized by numerous awards including the 2024 Lasker Public Service Award.
The endowed Training Program will provide opportunities to build capacity among medical and science Fellows from developing countries. It is hoped that the gift will support your continuous impact in addressing current and future endemic or pandemic challenges.
Website: CAPRISA.org
The Endowed Chair will honor John Martin’s legacy of innovation and dedication to improving patient health, and serve as an investment in the future, faculty and patients of the UC San Diego School of Medicine.